Thus, our findings show that the majority of CRC exhibits an activated functional caspase-1/IL-18 axis in tumor cells, and that IL-18 is able to modulate the IFNγ response of TILs in vitro. The gene discussed is IFNG; the disease is colorectal carcinoma.